AMPK senses cellular levels of nicotinamide adenine dinucleotide
Wilson, N.; Rabanal Ruiz, Y.; Bishnu, A.; Xu, S.; Sun, C.; Ahangar, M. S.; Rattigan, K. M.; Tang, J.; Silva-Amaral, D.; Fraguas Bringas, C.; Sakamoto, K.; Kataura, T.; Sarkar, S.; Zeqiraj, E.; Helgason, G. V.; Ganley, I.; Bronowska, A.; Korolchuk, V. I.
Show abstract
The electron shuttle and coenzyme nicotinamide adenine nucleotide (NAD) is essential for cellular metabolism and homeostasis. NAD levels significantly fluctuate in cells, whilst several age-related diseases are associated with depletion of this metabolite. However, how NAD changes are monitored by nutrient/energy sensing signalling pathways remains poorly understood. We found that at physiological concentrations NAD controls the activity of the AMP-activated protein kinase (AMPK) in vitro and in human cells. Mechanistically, NAD binds gamma subunit of AMPK, and mutagenesis of the putative binding site renders the holoenzyme insensitive to NAD inhibition. Hyperactivation of AMPK in response to NAD depletion suppresses metabolic pathways including mammalian Target of Rapamycin Complex I (mTORC1) and autophagy. These results demonstrate that in addition to monitoring cellular energy levels AMPK functions as a NAD sensor, providing novel insight into how cells and tissues detect and respond to metabolic fluctuations with implications for stress resistance and ageing.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.